HHMI
EDIT icon

Howard Hughes Medical Institute’s Editas Medicine EDIT Stock Holding History

Howard Hughes Medical Institute’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,980
Closed -$50K – 62
2017
Q2 		$50K Buy
2,980
+182
+7% +$3.28K 0.01% 150
2017
Q1 		$62K Sell
2,798
-5
-0.2% -$104 0.01% 144
2016
Q4 		$45K Buy
2,803
+246
+10% +$3.73K 0.01% 141
2016
Q3 		$34K Sell
2,557
-588
-19% -$12K 0.01% 146
2016
Q2 		$77K Buy
+3,145
New +$106K 0.03% 140

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Howard Hughes Medical Institute's EDIT Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Editas Medicine (EDIT) in Q3 2017, closing a stake of 2,980 shares — an estimated $50K sold.

Howard Hughes Medical Institute first reported a position in EDIT in Q2 2016 and held it in 5 quarters. The position peaked at $77K in Q2 2016. 116 funds tracked by Wall St. Rank hold EDIT as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Editas Medicine position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 2,980 Editas Medicine shares in Q3 2017, an estimated $50K.
  • Howard Hughes Medical Institute first reported a position in Editas Medicine in Q2 2016 and held it in 5 quarters.
  • Howard Hughes Medical Institute's Editas Medicine position peaked at $77K in Q2 2016.
  • 116 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.